Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. GSIW
GSIW logo

GSIW Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
27.000
Open
26.725
VWAP
26.04
Vol
16.83K
Mkt Cap
29.53M
Low
25.560
Amount
438.25K
EV/EBITDA(TTM)
--
Total Shares
1.09M
EV
278.33M
EV/OCF(TTM)
--
P/S(TTM)
--
Garden Stage Ltd is a holding company principally engaged in the provision of financial services. The Company is principally engaged in the provision of securities dealing and brokerage services, securities underwriting and placing services, asset management services as well as others.
Show More

Events Timeline

(ET)
2026-03-10
09:40:00
Garden Stage Ltd Trading Halted Due to Volatility Trading Pause
select
2026-03-09 (ET)
2026-03-09
10:40:00
Garden Stage Ltd Trading Halted Due to Volatility Trading Pause
select
2026-03-06 (ET)
2026-03-06
09:40:00
Garden Stage Ltd Trading Halted Due to Volatility Trading Pause
select
2026-03-05 (ET)
2026-03-05
20:00:00
Garden Stage Ltd Trading Halted, News Pending
select
2025-09-07 (ET)
2025-09-07
11:36:11
Garden Stage Gets Nasdaq Alert About Minimum Bid Price Shortfall
select
2025-07-24 (ET)
2025-07-24
14:42:55
Garden Stage announces $4.2M registered direct offering
select

News

Benzinga
9.5
03-10Benzinga
Zevra Therapeutics Reports Strong Q4 Earnings, Shares Surge
  • Earnings Beat: Zevra Therapeutics reported Q4 earnings of $0.19 per share, significantly surpassing the analyst consensus of $0.05, indicating a notable improvement in profitability and boosting investor confidence.
  • Sales Growth: The company achieved quarterly sales of $34.125 million, exceeding the analyst estimate of $28.051 million, reflecting strong product demand and solid market performance, which may drive future growth potential.
  • Stock Surge: Following the earnings report, Zevra Therapeutics shares jumped 17.2% to $10.70 in pre-market trading, indicating a positive market reaction to the company's performance and potentially attracting more investor interest.
  • Optimistic Market Outlook: This earnings beat not only enhances the company's short-term stock price but may also lay a foundation for long-term development, strengthening market confidence in its future growth prospects.
Benzinga
9.5
03-09Benzinga
Relmada Therapeutics Shares Surge 40.8% on Promising Trial Data
  • Market Decline: U.S. stocks fell broadly on Monday, with the Dow Jones index dropping around 650 points, indicating investor concerns about economic outlook which may impact consumer spending and overall market confidence.
  • Relmada Stock Surge: Shares of Relmada Therapeutics Inc. soared 40.8% to $6.27 during Monday's session, driven by the release of promising interim data from its Phase 2 trial of NDV-01 for treating non-muscle invasive bladder cancer.
  • Clinical Trial Results: The 12-month interim data revealed a complete response rate of 76%, with an impressive 80% in the BCG-unresponsive patient population, providing strong support for Relmada's treatment approach and potentially enhancing market acceptance.
  • Positive Market Reaction: The favorable feedback from clinical data has led to optimistic investor sentiment regarding Relmada's future prospects, not only boosting the company's stock price but also likely attracting more investor interest in its ongoing research and development efforts.
Benzinga
4.5
03-04Benzinga
U.S. Stocks Rise in Morning Trading, Dow Jones Up Over 100 Points
  • Dow Jones Performance: The Dow Jones index gained over 100 points on Wednesday, rising 0.25% to close at 48,622.74, indicating positive market sentiment and increased investor confidence.
  • NASDAQ and S&P 500 Rise: The NASDAQ climbed 0.69% to 22,672.12, while the S&P 500 rose 0.37% to 6,841.53, reflecting strong performances in the technology and consumer sectors.
  • Abercrombie & Fitch Earnings: The company reported Q4 earnings of $3.68 per share, beating analyst expectations of $3.57, yet its stock fell around 5%, indicating market concerns about future performance.
  • Private Sector Job Data: U.S. private businesses added 63,000 jobs in February, significantly exceeding market estimates of 50,000, suggesting a robust economic recovery that could positively impact the stock market.
seekingalpha
8.5
03-04seekingalpha
Garden Stage Limited Announces 200-for-1 Share Consolidation
  • Share Consolidation Plan: Garden Stage Limited announced a 200-for-1 share consolidation effective March 6 to comply with Nasdaq Marketplace Rule 5550(a)(2), aiming to enhance investor confidence and maintain its listing status.
  • Trading Symbol Unchanged: Post-consolidation, the company's Class A shares will continue trading on the Nasdaq Capital Market under the symbol 'GSIW', but with a new CUSIP number G3730L131, ensuring market liquidity and transparency.
  • Change in Share Count: Before the consolidation, the company had 282,485,623 Class A shares outstanding, which is expected to reduce to approximately 1,412,428 shares post-consolidation, while Class B shares will remain unchanged at 9,250,000, reflecting the company's efforts to optimize its capital structure.
  • Market Reaction: Following the consolidation announcement, GSIW's stock price fell 36.88% in pre-market trading to $0.0568, indicating market caution regarding the company's future prospects, which may impact investor confidence and subsequent financing capabilities.
moomoo
9.0
03-04moomoo
GARDEN STAGE LIMITED DECLARES 200 FOR 1 CONSOLIDATION OF CLASS A SHARES
  • Company Announcement: Gardens Stage Limited has announced a consolidation of Class A shares.
  • Share Conversion Rate: The consolidation will occur at a rate of 200 for 1 share.
Newsfilter
8.5
02-11Newsfilter
Garden Stage Announces Share Reclassification
  • Share Reclassification Details: Garden Stage Limited announced a reclassification of its ordinary shares effective February 12, 2026, on the Nasdaq, changing its authorized share capital from $50,000 to 425,968,655 unissued Class A ordinary shares, aimed at optimizing capital structure and enhancing market competitiveness.
  • Capital Structure Adjustment: Following the reclassification, 9,250,000 ordinary shares held by Oriental Moon Tree Limited will be redesignated as Class B ordinary shares, while 64,781,655 ordinary shares will become Class A ordinary shares, ensuring all shareholder rights are preserved in accordance with the company's articles of association.
  • Company Operational Background: Garden Stage Limited is a holding company incorporated in the Cayman Islands, with wholly-owned subsidiaries in Hong Kong, including I Win Securities Limited and I Win Asset Management Limited, which are licensed for securities dealing and asset management, respectively, strengthening its market position in financial services.
  • Forward-Looking Statements: The company included forward-looking statements in its announcement, indicating that future business strategies and financial needs may be influenced by various known and unknown risks, and while optimistic about future expectations, actual results may differ significantly, urging investors to carefully assess related risks.

Valuation Metrics

The current forward P/E ratio for Garden Stage Ltd (GSIW.O) is 0.00, compared to its 5-year average forward P/E of 0.00. For a more detailed relative valuation and DCF analysis to assess Garden Stage Ltd's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
0.00
Current PE
0.00
Overvalued PE
0.00
Undervalued PE
0.00

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
0.00
Current PS
0.00
Overvalued PS
0.00
Undervalued PS
0.00

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

stocks under 2$
Intellectia · 732 candidates
Price: $0.00 - $2.00List Exchange: XNYS, XNAS, XASE
Ticker
Name
Market Cap$
top bottom
TIRX logo
TIRX
Tian Ruixiang Holdings Ltd
6.37M
STFS logo
STFS
Star Fashion Culture Holdings Ltd
4.80M
PTLE logo
PTLE
PTL Ltd
10.47M
CENN logo
CENN
Cenntro Inc (The Corporation)
11.05M
JTAI logo
JTAI
Jet.AI Inc
4.96M
WCT logo
WCT
Wellchange Holdings Co Ltd
20.03M
stocks with short squeeze
Intellectia · 297 candidates
Short Ratio: MoreThan30PctList Exchange: XNYS, XNAS, XASE
Ticker
Name
Market Cap$
top bottom
PMN logo
PMN
ProMIS Neurosciences Inc
25.87M
PHGE logo
PHGE
Biomx Inc
8.95M
SGMO logo
SGMO
Sangamo Therapeutics Inc
164.85M
ATYR logo
ATYR
aTyr Pharma Inc
82.28M
MOD logo
MOD
Modine Manufacturing Co
9.83B
LDWY logo
LDWY
Lendway Inc
8.42M
Stocks under 1 dollar
Intellectia · 291 candidates
Price: $0.00 - $1.00List Exchange: XNYS, XNAS, XASE
Ticker
Name
Market Cap$
top bottom
MTEN logo
MTEN
Mingteng International Corp Inc
4.13M
ATPC logo
ATPC
Agape ATP Corp
3.93M
SXTC logo
SXTC
China SXT Pharmaceuticals Inc
10.96M
APLT logo
APLT
Applied Therapeutics Inc
15.14M
MKDW logo
MKDW
MKDWELL Tech Inc
12.07M
PTLE logo
PTLE
PTL Ltd
11.70M
Stocks under 1$
Intellectia · 374 candidates
Price: <= $1.00
Ticker
Name
Market Cap$
top bottom
MTEN logo
MTEN
Mingteng International Corp Inc
4.13M
ATPC logo
ATPC
Agape ATP Corp
3.93M
SXTC logo
SXTC
China SXT Pharmaceuticals Inc
10.96M
APLT logo
APLT
Applied Therapeutics Inc
15.14M
MKDW logo
MKDW
MKDWELL Tech Inc
12.07M
PFSA logo
PFSA
Profusa Inc
9.85M
best penny stock under 10 dollars today
Intellectia · 1578 candidates
Price: <= $10.00Market Cap Category: micro, nano
Ticker
Name
Market Cap$
top bottom
MTEN logo
MTEN
Mingteng International Corp Inc
5.55M
ATPC logo
ATPC
Agape ATP Corp
4.10M
SXTC logo
SXTC
China SXT Pharmaceuticals Inc
11.70M
CCTG logo
CCTG
CCSC Technology International Holdings Ltd
3.84M
APLT logo
APLT
Applied Therapeutics Inc
14.63M
PTLE logo
PTLE
PTL Ltd
10.48M
what stocks are recommended to sell short
Intellectia · 35 candidates
Relative Vol: >= 1.50Short Ratio: MoreThan30PctMoving Average Relationship: PriceBelowMA200
Ticker
Name
Market Cap$
top bottom
MMYT logo
MMYT
MakeMyTrip Ltd
6.22B
WH logo
WH
Wyndham Hotels & Resorts Inc
6.01B
WIX logo
WIX
Wix.Com Ltd
4.37B
NMAX logo
NMAX
Newsmax Inc
995.59M
FBYD logo
FBYD
Falcon's Beyond Global Inc
805.67M
NFE logo
NFE
New Fortress Energy Inc
441.06M
stocks under $1 likely to be bullish monday
Intellectia · 23 candidates
Price: <= $1.00Relative Vol: >= 1.50Moving Average Relationship: PriceAboveMA5
Ticker
Name
Market Cap$
top bottom
BRCC logo
BRCC
BRC Inc
247.13M
SFWL logo
SFWL
SHENGFENG DEVELOPMENT Ltd
78.32M
MDIA logo
MDIA
Mediaco Holding Inc
57.16M
KWM logo
KWM
K Wave Media Ltd
50.24M
ZENV logo
ZENV
Zenvia Inc
47.05M
CUE logo
CUE
Cue Biopharma Inc
34.28M
what stock show this heading into tomrrow
Intellectia · 9 candidates
Price: <= $0.40Rsi 14: >= 45Moving Average Relationship: PriceAboveMA5Week Price Change Pct: >= $-2.00
Ticker
Name
Market Cap$
top bottom
RYDE logo
RYDE
Ryde Group Ltd
42.57M
CUE logo
CUE
Cue Biopharma Inc
34.28M
GSIW logo
GSIW
Garden Stage Ltd
31.74M
JOB logo
JOB
GEE Group Inc
23.64M
PFSA logo
PFSA
Profusa Inc
9.90M
SKYQ logo
SKYQ
Sky Quarry Inc
9.81M
what is a penny stock likely to do well
Intellectia · 14 candidates
Market Cap: <= 500.00MPrice: <= $5.00Relative Vol: >= 1.50Month Price Change Pct: >= $0.00Annual Revenue Yoy Growth: >= 20.0%
Ticker
Name
Market Cap$
top bottom
SATL logo
SATL
Satellogic Inc
486.33M
EMPD logo
EMPD
Empery Digital Inc
168.58M
LUCD logo
LUCD
Lucid Diagnostics Inc
148.14M
ROMA logo
ROMA
Roma Green Finance Ltd
143.55M
MDIA logo
MDIA
Mediaco Holding Inc
57.16M
DXST logo
DXST
Decent Holding Inc
52.95M
strong short-term buy under .70
Intellectia · 8 candidates
Price: <= $0.70Relative Vol: >= 1.50Rsi 14: 30 - 70Moving Average Relationship: PriceAboveMA5Week Price Change Pct: >= $0.00
Ticker
Name
Market Cap$
top bottom
MDIA logo
MDIA
Mediaco Holding Inc
57.16M
CUE logo
CUE
Cue Biopharma Inc
34.28M
GSIW logo
GSIW
Garden Stage Ltd
31.74M
AERT logo
AERT
Aeries Technology Inc
29.01M
SCYX logo
SCYX
SCYNEXIS Inc
28.05M
COSM logo
COSM
Cosmos Health Inc
19.42M

Whales Holding GSIW

L
L1 Capital Pty. Limited
Holding
GSIW
+18.67%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Garden Stage Ltd (GSIW) stock price today?

The current price of GSIW is 25.56 USD — it has decreased -5.58

What is Garden Stage Ltd (GSIW)'s business?

Garden Stage Ltd is a holding company principally engaged in the provision of financial services. The Company is principally engaged in the provision of securities dealing and brokerage services, securities underwriting and placing services, asset management services as well as others.

What is the price predicton of GSIW Stock?

Wall Street analysts forecast GSIW stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for GSIW is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Garden Stage Ltd (GSIW)'s revenue for the last quarter?

Garden Stage Ltd revenue for the last quarter amounts to -368.03 USD, decreased -54.64

What is Garden Stage Ltd (GSIW)'s earnings per share (EPS) for the last quarter?

Garden Stage Ltd. EPS for the last quarter amounts to USD, decreased

How many employees does Garden Stage Ltd (GSIW). have?

Garden Stage Ltd (GSIW) has 17 emplpoyees as of March 11 2026.

What is Garden Stage Ltd (GSIW) market cap?

Today GSIW has the market capitalization of 29.53M USD.